ARTICLE | Politics, Policy & Law
Footnote or forecast?
White House report calls for public-partnership to fix drug R&D
October 8, 2012 7:00 AM UTC
The President's Council on Advisors on Science and Technology (PCAST) spent a year working on a report titled Propelling Innovation in Drug Discovery, Development, and Evaluation, and now the authors are trying to ensure it doesn't become just a footnote in future blue ribbon reports.
According to the blue ribbon panel, the best way to fill the gaps identified by PCAST's report - the need for more and better translational research, improving clinical trial capabilities and clarifying regulatory pathways - is to create a high-level Partnership to Accelerate Therapeutics Innovation...